Smartlab Europe

Press Releases

Venturing into chemicals in France

Invest in Grenoble-Isère and Rhône Valley - ACHEMA 2015 Hall 9.2, stand D41 Adisseo, Hexcel, Vencorex, Arkema… major international chemical industry stakeholders are investing more than a billion euros in Grenoble-Isère and the Rhône Valley (France). ...

ThyssenKrupp Uhde Chlorine Engineers and McPhy Energy seal a strategic commercial alliance in the area of hydrogen generation

McPhy Energy to become ThyssenKrupp Uhde Chlorine Engineers’ exclusive supplier for high-capacity, high-pressure hydrogen generation equipment for the carbon-free mobility and renewable energy sectors. ThyssenKrupp Uhde Chlorine Engineers, a world leader for chlor-alkali and hydrochloric acid...

AMPO FOUNDRY OFFERS HIGH-ADDED-VALUE VALVE, PUMP & POWER GENERATION COMPONENTS

AMPO, a leading foundry specialising in stainless steel and high alloy castings, with over 50 years’ experience, is an international company with a clear ability for innovation and developing processes, products and technologies. Given the reliability...

At Pack/Pharma Expo, DIR Technologies to Debut “Lite” Version of Thermal Image-driven Induction Seal Inspection Solution for Bottles

Viable for Non-Pharma Sectors such as Food and Cosmetics, New Simplified System Provides Induction Sealing Integrity Analysis for 100% of Bottles without Packaging Line Slowdown Haifa, Israel – At Pack/Pharma Expo Las Vegas September 28-30, DIR Technologies,...

Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European League

Bristol-Myers Squibb Company (NYSE:BMY) announced that 14 abstracts on Orencia have been accepted for presentation at the 2015 annual meeting of the European League Against Rheumatism (EULAR), to be held June 10-13 in Rome, Italy.  ...

Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk of Disease Progression, According to New Phase III Data from...

Bristol-Myers Squibb Company (NYSE:BMY) and AbbVie (NYSE:ABBV) today announced that results from an interim analysis of its Phase III, randomized, open-label ELOQUENT-2 trial were published in the June 2 online edition of the New England Journal of Medicine. ...

Bristol-Myers Squibb to Take Part in Goldman Sachs 36th Annual Global Health Care Conference

Bristol-Myers Squibb Company (NYSE:BMY) will take part in Goldman Sachs 36th Annual Global Health Care Conference on Tuesday, June 9, 2015, in Rancho Palos Verdes, CA. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »